{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T19:21:50Z","timestamp":1793128910100,"version":"4.5.0"},"reference-count":187,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T00:00:00Z","timestamp":1605484800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T00:00:00Z","timestamp":1605484800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Skeletal Muscle"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The<jats:italic>RYR1<\/jats:italic>gene, which encodes the sarcoplasmic reticulum calcium release channel or type 1 ryanodine receptor (RyR1) of skeletal muscle, was sequenced in 1988 and<jats:italic>RYR1<\/jats:italic>variations that impair calcium homeostasis and increase susceptibility to malignant hyperthermia were first identified in 1991. Since then,<jats:italic>RYR1<\/jats:italic>-related myopathies (<jats:italic>RYR1<\/jats:italic>-RM) have been described as rare, histopathologically and clinically heterogeneous, and slowly progressive neuromuscular disorders.<jats:italic>RYR1<\/jats:italic>variants can lead to dysfunctional RyR1-mediated calcium release, malignant hyperthermia susceptibility, elevated oxidative stress, deleterious post-translational modifications, and decreased RyR1 expression.<jats:italic>RYR1<\/jats:italic>-RM-affected individuals can present with delayed motor milestones, contractures, scoliosis, ophthalmoplegia, and respiratory insufficiency.<\/jats:p><jats:p>Historically,<jats:italic>RYR1<\/jats:italic>-RM-affected individuals were diagnosed based on morphologic features observed in muscle biopsies including central cores, cores and rods, central nuclei, fiber type disproportion, and multi-minicores. However, these histopathologic features are not always specific to<jats:italic>RYR1<\/jats:italic>-RM and often change over time. As additional phenotypes were associated with<jats:italic>RYR1<\/jats:italic>variations (including King-Denborough syndrome, exercise-induced rhabdomyolysis, lethal multiple pterygium syndrome, adult-onset distal myopathy, atypical periodic paralysis with or without myalgia, mild calf-predominant myopathy, and dusty core disease) the overlap among diagnostic categories is ever increasing. With the continuing emergence of new clinical subtypes along the<jats:italic>RYR1<\/jats:italic>disease spectrum and reports of adult-onset phenotypes, nuanced nomenclatures have been reported (<jats:italic>RYR1<\/jats:italic>- [related, related congenital, congenital] myopathies). In this narrative review, we provide historical highlights of<jats:italic>RYR1<\/jats:italic>research, accounts of the main diagnostic disease subtypes and propose<jats:italic>RYR1<\/jats:italic>-related disorders (<jats:italic>RYR1<\/jats:italic>-RD) as a unified nomenclature to describe this complex and evolving disease spectrum.<\/jats:p>","DOI":"10.1186\/s13395-020-00243-4","type":"journal-article","created":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T03:04:42Z","timestamp":1605495882000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":97,"title":["Ryanodine receptor 1-related disorders: an historical perspective and proposal for a unified nomenclature"],"prefix":"10.1186","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3007-820X","authenticated-orcid":false,"given":"Tokunbor A.","family":"Lawal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua J.","family":"Todd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica W.","family":"Witherspoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten G.","family":"B\u00f6nnemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Dowling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan L.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine G.","family":"Meilleur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert T.","family":"Dirksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,16]]},"reference":[{"issue":"02","key":"243_CR1","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1055\/s-0028-1091869","volume":"1","author":"V Dubowitz","year":"1969","unstructured":"Dubowitz V. The \u201cnew\u201d myopathies. Neuropediatrics. 1969;1(02):137\u201348.","journal-title":"Neuropediatrics."},{"issue":"2","key":"243_CR2","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.nmd.2013.11.003","volume":"24","author":"KN North","year":"2014","unstructured":"North KN, Wang CH, Clarke N, Jungbluth H, Vainzof M, Dowling JJ, et al. Approach to the diagnosis of congenital myopathies. Neuromuscul Disord. 2014;24(2):97\u2013116.","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"243_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-016-0392-6","volume":"4","author":"JW Witherspoon","year":"2016","unstructured":"Witherspoon JW, Meilleur KG. Review of RyR1 pathway and associated pathomechanisms. Acta Neuropathol Commun. 2016;4(1):121.","journal-title":"Acta Neuropathol Commun"},{"issue":"6154","key":"243_CR4","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/331315a0","volume":"331","author":"FA Lai","year":"1988","unstructured":"Lai FA, Erickson HP, Rousseau E, Liu QY, Meissner G. Purification and reconstitution of the calcium release channel from skeletal muscle. Nature. 1988;331(6154):315\u20139.","journal-title":"Nature."},{"issue":"5018","key":"243_CR5","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1126\/science.1862346","volume":"253","author":"J Fujii","year":"1991","unstructured":"Fujii J, Otsu K, Zorzato F, de Leon S, Khanna VK, Weiler JE, et al. Identification of a mutation in porcine ryanodine receptor associated with malignant hyperthermia. Science (New York, NY). 1991;253(5018):448\u201351.","journal-title":"Science (New York, NY)"},{"issue":"3","key":"243_CR6","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.coph.2008.01.005","volume":"8","author":"S Treves","year":"2008","unstructured":"Treves S, Jungbluth H, Muntoni F, Zorzato F. Congenital muscle disorders with cores: the ryanodine receptor calcium channel paradigm. Curr Opin Pharmacol. 2008;8(3):319\u201326.","journal-title":"Curr Opin Pharmacol"},{"issue":"5","key":"243_CR7","doi-asserted-by":"publisher","first-page":"391","DOI":"10.4097\/kjae.2012.63.5.391","volume":"63","author":"DC Kim","year":"2012","unstructured":"Kim DC. Malignant hyperthermia. Korean J Anesthesiol. 2012;63(5):391\u2013401.","journal-title":"Korean J Anesthesiol"},{"issue":"4","key":"243_CR8","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1093\/bja\/aev225","volume":"115","author":"PM Hopkins","year":"2015","unstructured":"Hopkins PM, Ruffert H, Snoeck MM, Girard T, Glahn KP, Ellis FR, et al. European malignant hyperthermia group guidelines for investigation of malignant hyperthermia susceptibility. Br J Anaesth. 2015;115(4):531\u20139.","journal-title":"Br J Anaesth"},{"issue":"1","key":"243_CR9","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.anclin.2019.10.010","volume":"38","author":"H Ellinas","year":"2020","unstructured":"Ellinas H, Albrecht MA. Malignant hyperthermia update. Anesthesiol Clin. 2020;38(1):165\u201381.","journal-title":"Anesthesiol Clin"},{"issue":"5","key":"243_CR10","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1097\/ALN.0b013e3182320068","volume":"115","author":"L Groom","year":"2011","unstructured":"Groom L, Muldoon SM, Tang ZZ, Brandom BW, Bayarsaikhan M, Bina S, et al. Identical de novo mutation in the type 1 ryanodine receptor gene associated with fatal, stress-induced malignant hyperthermia in two unrelated families. Anesthesiology. 2011;115(5):938\u201345.","journal-title":"Anesthesiology."},{"issue":"2","key":"243_CR11","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/nm.2598","volume":"18","author":"JT Lanner","year":"2012","unstructured":"Lanner JT, Georgiou DK, Dagnino-Acosta A, Ainbinder A, Cheng Q, Joshi AD, et al. AICAR prevents heat-induced sudden death in RyR1 mutant mice independent of AMPK activation. Nat Med. 2012;18(2):244\u201351.","journal-title":"Nat Med"},{"issue":"4","key":"243_CR12","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1213\/ane.0b013e3181a9d8d9","volume":"109","author":"JF Capacchione","year":"2009","unstructured":"Capacchione JF, Muldoon SM. The relationship between exertional heat illness, exertional rhabdomyolysis, and malignant hyperthermia. Anesth Analg. 2009;109(4):1065\u20139.","journal-title":"Anesth Analg"},{"key":"243_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-015-0310-1","volume":"10","author":"H Rosenberg","year":"2015","unstructured":"Rosenberg H, Pollock N, Schiemann A, Bulger T, Stowell K. Malignant hyperthermia: a review. Orphanet J Rare Dis. 2015;10:93.","journal-title":"Orphanet J Rare Dis"},{"issue":"42","key":"243_CR14","doi-asserted-by":"publisher","first-page":"26332","DOI":"10.1074\/jbc.272.42.26332","volume":"272","author":"J Tong","year":"1997","unstructured":"Tong J, Oyamada H, Demaurex N, Grinstein S, McCarthy TV, MacLennan DH. Caffeine and halothane sensitivity of intracellular Ca2+ release is altered by 15 calcium release channel (ryanodine receptor) mutations associated with malignant hyperthermia and\/or central core disease. J Biol Chem. 1997;272(42):26332\u20139.","journal-title":"J Biol Chem"},{"issue":"5","key":"243_CR15","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S1050-1738(02)00163-9","volume":"12","author":"RT Dirksen","year":"2002","unstructured":"Dirksen RT, Avila G. Altered ryanodine receptor function in central core disease: leaky or uncoupled ca(2+) release channels? Trends Cardiovasc Med. 2002;12(5):189\u201397.","journal-title":"Trends Cardiovasc Med"},{"issue":"1","key":"243_CR16","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1085\/jgp.201010523","volume":"137","author":"RE Loy","year":"2011","unstructured":"Loy RE, Orynbayev M, Xu L, Andronache Z, Apostol S, Zvaritch E, et al. Muscle weakness in Ryr1I4895T\/WT knock-in mice as a result of reduced ryanodine receptor Ca2+ ion permeation and release from the sarcoplasmic reticulum. J Gen Physiol. 2011;137(1):43\u201357.","journal-title":"J Gen Physiol"},{"issue":"7","key":"243_CR17","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.1073\/pnas.071048198","volume":"98","author":"G Avila","year":"2001","unstructured":"Avila G, O'Brien JJ, Dirksen RT. Excitation--contraction uncoupling by a human central core disease mutation in the ryanodine receptor. Proc Natl Acad Sci U S A. 2001;98(7):4215\u201320.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"243_CR18","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s13311-014-0300-3","volume":"11","author":"JJ Dowling","year":"2014","unstructured":"Dowling JJ, Lawlor MW, Dirksen RT. Triadopathies: an emerging class of skeletal muscle diseases. Neurotherapeutics. 2014;11(4):773\u201385.","journal-title":"Neurotherapeutics."},{"issue":"4","key":"243_CR19","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1002\/ana.22510","volume":"70","author":"K Amburgey","year":"2011","unstructured":"Amburgey K, McNamara N, Bennett LR, McCormick ME, Acsadi G, Dowling JJ. Prevalence of congenital myopathies in a representative pediatric United States population. Ann Neurol. 2011;70(4):662\u20135.","journal-title":"Ann Neurol"},{"issue":"4","key":"243_CR20","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1002\/ajmg.a.38418","volume":"176","author":"JJ Dowling","year":"2018","unstructured":"Dowling JJ. H DG, Cohn RD, Campbell C. treating pediatric neuromuscular disorders: the future is now. Am J Med Genet A. 2018;176(4):804\u201341.","journal-title":"Am J Med Genet A"},{"issue":"5","key":"243_CR21","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1097\/ALN.0b013e3182a8a8e7","volume":"119","author":"SG Gonsalves","year":"2013","unstructured":"Gonsalves SG, Ng D, Johnston JJ, Teer JK, Stenson PD, Cooper DN, et al. Using exome data to identify malignant hyperthermia susceptibility mutations. Anesthesiology. 2013;119(5):1043\u201353.","journal-title":"Anesthesiology."},{"key":"243_CR22","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/1750-1172-8-117","volume":"8","author":"K Amburgey","year":"2013","unstructured":"Amburgey K, Bailey A, Hwang JH, Tarnopolsky MA, Bonnemann CG, Medne L, et al. Genotype-phenotype correlations in recessive RYR1-related myopathies. Orphanet J Rare Dis. 2013;8:117.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"243_CR23","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s11910-008-0012-3","volume":"8","author":"A D'Amico","year":"2008","unstructured":"D'Amico A, Bertini E. Congenital myopathies. Curr Neurol Neurosci Rep. 2008;8(1):73\u20139.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"243_CR24","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3389\/fneur.2018.00118","volume":"9","author":"JJ Todd","year":"2018","unstructured":"Todd JJ, Razaqyar MS, Witherspoon JW, Lawal TA, Mankodi A, Chrismer IC, et al. Novel variants in individuals with RYR1-related congenital myopathies: genetic, laboratory, and clinical findings. Front Neurol. 2018;9:118.","journal-title":"Front Neurol"},{"issue":"2","key":"243_CR25","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.pediatrneurol.2014.04.024","volume":"51","author":"J Rocha","year":"2014","unstructured":"Rocha J, Taipa R, Melo Pires M, Oliveira J, Santos R, Santos M. Ryanodine myopathies without central cores--clinical, histopathologic, and genetic description of three cases. Pediatr Neurol. 2014;51(2):275\u20138.","journal-title":"Pediatr Neurol"},{"issue":"3","key":"243_CR26","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1093\/brain\/96.3.527","volume":"96","author":"JA Morgan-Hughes","year":"1973","unstructured":"Morgan-Hughes JA, Brett EM, Lake BD, Tome FM. Central core disease or not? Observations on a family with a non-progressive myopathy. Brain. 1973;96(3):527\u201336.","journal-title":"Brain."},{"issue":"9","key":"243_CR27","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.nmd.2016.06.001","volume":"26","author":"H Jungbluth","year":"2016","unstructured":"Jungbluth H, Dowling JJ, Ferreiro A, Muntoni F. 217th ENMC international workshop: RYR1-related myopathies, Naarden, the Netherlands, 29-31 January 2016. Neuromuscul Disord. 2016;26(9):624\u201333.","journal-title":"Neuromuscul Disord"},{"key":"243_CR28","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/B978-0-444-64076-5.00036-3","volume":"148","author":"HD Gonorazky","year":"2018","unstructured":"Gonorazky HD, Bonnemann CG, Dowling JJ. The genetics of congenital myopathies. Handb Clin Neurol. 2018;148:549\u201364.","journal-title":"Handb Clin Neurol"},{"issue":"1","key":"243_CR29","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S1090-3798(02)00136-8","volume":"7","author":"H Jungbluth","year":"2003","unstructured":"Jungbluth H, Sewry CA, Muntoni F. What's new in neuromuscular disorders? The congenital myopathies. Eur J Paediatr Neurol. 2003;7(1):23\u201330.","journal-title":"Eur J Paediatr Neurol"},{"issue":"7","key":"243_CR30","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1111\/ene.12713","volume":"22","author":"M Snoeck","year":"2015","unstructured":"Snoeck M, van Engelen BG, Kusters B, Lammens M, Meijer R, Molenaar JP, et al. RYR1-related myopathies: a wide spectrum of phenotypes throughout life. Eur J Neurol. 2015;22(7):1094\u2013112.","journal-title":"Eur J Neurol"},{"issue":"6","key":"243_CR31","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.nmd.2011.03.006","volume":"21","author":"JJ Dowling","year":"2011","unstructured":"Dowling JJ, Lillis S, Amburgey K, Zhou H, Al-Sarraj S, Buk SJ, et al. King-Denborough syndrome with and without mutations in the skeletal muscle ryanodine receptor (RYR1) gene. Neuromuscul Disord. 2011;21(6):420\u20137.","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"243_CR32","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0022-3476(73)80309-9","volume":"83","author":"JO King","year":"1973","unstructured":"King JO, Denborough MA. Anesthetic-induced malignant hyperpyrexia in children. J Pediatr. 1973;83(1):37\u201340.","journal-title":"J Pediatr"},{"issue":"2","key":"243_CR33","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1212\/01.wnl.0000269792.63927.86","volume":"70","author":"I Sato","year":"2008","unstructured":"Sato I, Wu S, Ibarra MC, Hayashi YK, Fujita H, Tojo M, et al. Congenital neuromuscular disease with uniform type 1 fiber and RYR1 mutation. Neurology. 2008;70(2):114\u201322.","journal-title":"Neurology."},{"issue":"5","key":"243_CR34","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/ane.12885","volume":"137","author":"N Witting","year":"2018","unstructured":"Witting N, Laforet P, Voermans NC, Roux-Buisson N, Bompaire F, Rendu J, et al. Phenotype and genotype of muscle ryanodine receptor rhabdomyolysis-myalgia syndrome. Acta Neurol Scand. 2018;137(5):452\u201361.","journal-title":"Acta Neurol Scand"},{"issue":"5","key":"243_CR35","doi-asserted-by":"publisher","first-page":"e412","DOI":"10.1212\/WNL.0000000000004894","volume":"90","author":"E Matthews","year":"2018","unstructured":"Matthews E, Neuwirth C, Jaffer F, Scalco RS, Fialho D, Parton M, et al. Atypical periodic paralysis and myalgia: a novel RYR1 phenotype. Neurology. 2018;90(5):e412\u2013e8.","journal-title":"Neurology."},{"issue":"435","key":"243_CR36","doi-asserted-by":"publisher","first-page":"ra68","DOI":"10.1126\/scisignal.aad9813","volume":"9","author":"RJ Lopez","year":"2016","unstructured":"Lopez RJ, Byrne S, Vukcevic M, Sekulic-Jablanovic M, Xu L, Brink M, et al. An RYR1 mutation associated with malignant hyperthermia is also associated with bleeding abnormalities. Sci Signal. 2016;9(435):ra68.","journal-title":"Sci Signal"},{"issue":"5","key":"243_CR37","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1097\/WCO.0000000000000372","volume":"29","author":"H Jungbluth","year":"2016","unstructured":"Jungbluth H, Voermans NC. Congenital myopathies: not only a paediatric topic. Curr Opin Neurol. 2016;29(5):642\u201350.","journal-title":"Curr Opin Neurol"},{"issue":"1","key":"243_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-018-0655-5","volume":"7","author":"M Garibaldi","year":"2019","unstructured":"Garibaldi M, Rendu J, Brocard J, Lacene E, Faure J, Brochier G, et al. 'Dusty core disease' (DuCD): expanding morphological spectrum of RYR1 recessive myopathies. Acta Neuropathol Commun. 2019;7(1):3.","journal-title":"Acta Neuropathol Commun"},{"issue":"6","key":"243_CR39","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1007\/s00415-012-6817-7","volume":"260","author":"S Loseth","year":"2013","unstructured":"Loseth S, Voermans NC, Torbergsen T, Lillis S, Jonsrud C, Lindal S, et al. A novel late-onset axial myopathy associated with mutations in the skeletal muscle ryanodine receptor (RYR1) gene. J Neurol. 2013;260(6):1504\u201310.","journal-title":"J Neurol"},{"issue":"5","key":"243_CR40","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.nmd.2009.02.005","volume":"19","author":"H Jungbluth","year":"2009","unstructured":"Jungbluth H, Lillis S, Zhou H, Abbs S, Sewry C, Swash M, et al. Late-onset axial myopathy with cores due to a novel heterozygous dominant mutation in the skeletal muscle ryanodine receptor (RYR1) gene. Neuromuscul Disord. 2009;19(5):344\u20137.","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"243_CR41","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3988\/jcn.2018.14.1.58","volume":"14","author":"HN Jeong","year":"2018","unstructured":"Jeong HN, Park HJ, Lee JH, Shin HY, Kim SH, Kim SM, et al. Clinical and pathologic findings of Korean patients with RYR1-related congenital myopathy. J Clin Neurol (Seoul, Korea). 2018;14(1):58\u201365.","journal-title":"J Clin Neurol (Seoul, Korea)"},{"issue":"17","key":"243_CR42","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1212\/WNL.0b013e3182900380","volume":"80","author":"DX Bharucha-Goebel","year":"2013","unstructured":"Bharucha-Goebel DX, Santi M, Medne L, Zukosky K, Dastgir J, Shieh PB, et al. Severe congenital RYR1-associated myopathy: the expanding clinicopathologic and genetic spectrum. Neurology. 2013;80(17):1584\u20139.","journal-title":"Neurology."},{"issue":"8","key":"243_CR43","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.nmd.2014.05.003","volume":"24","author":"MA Illingworth","year":"2014","unstructured":"Illingworth MA, Main M, Pitt M, Feng L, Sewry CA, Gunny R, et al. RYR1-related congenital myopathy with fatigable weakness, responding to pyridostigimine. Neuromuscul Disord. 2014;24(8):707\u201312.","journal-title":"Neuromuscul Disord"},{"issue":"12","key":"243_CR44","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.041368","volume":"12","author":"A Fusto","year":"2019","unstructured":"Fusto A, Moyle LA, Gilbert PM, Pegoraro E. Cored in the act: the use of models to understand core myopathies. Dis Model Mech. 2019;12(12):dmm041368.","journal-title":"Dis Model Mech"},{"issue":"3","key":"243_CR45","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/nrneurol.2017.191","volume":"14","author":"H Jungbluth","year":"2018","unstructured":"Jungbluth H, Treves S, Zorzato F, Sarkozy A, Ochala J, Sewry C, et al. Congenital myopathies: disorders of excitation-contraction coupling and muscle contraction. Nat Rev Neurol. 2018;14(3):151\u201367.","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"243_CR46","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s13311-018-00677-1","volume":"15","author":"TA Lawal","year":"2018","unstructured":"Lawal TA, Todd JJ, Meilleur KG. Ryanodine receptor 1-related myopathies: diagnostic and therapeutic approaches. Neurotherapeutics. 2018;15(4):885\u201399.","journal-title":"Neurotherapeutics."},{"issue":"1","key":"243_CR47","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/0014-5793(92)80208-X","volume":"301","author":"JR Mickelson","year":"1992","unstructured":"Mickelson JR, Knudson CM, Kennedy CF, Yang DI, Litterer LA, Rempel WE, et al. Structural and functional correlates of a mutation in the malignant hyperthermia-susceptible pig ryanodine receptor. FEBS Lett. 1992;301(1):49\u201352.","journal-title":"FEBS Lett"},{"issue":"1","key":"243_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-020-01384-x","volume":"15","author":"TA Lawal","year":"2020","unstructured":"Lawal TA, Wires ES, Terry NL, Dowling JJ, Todd JJ. Preclinical model systems of ryanodine receptor 1-related myopathies and malignant hyperthermia: a comprehensive scoping review of works published 1990-2019. Orphanet J Rare Dis. 2020;15(1):113.","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"243_CR49","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1152\/physrev.1996.76.2.537","volume":"76","author":"JR Mickelson","year":"1996","unstructured":"Mickelson JR, Louis CF. Malignant hyperthermia: excitation-contraction coupling, Ca2+ release channel, and cell Ca2+ regulation defects. Physiol Rev. 1996;76(2):537\u201392.","journal-title":"Physiol Rev"},{"issue":"4","key":"243_CR50","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1093\/brain\/79.4.610","volume":"79","author":"KR Magee","year":"1956","unstructured":"Magee KR, Shy GM. A new congenital non-progressive myopathy. Brain : a journal of neurology. 1956;79(4):610\u201321.","journal-title":"Brain : a journal of neurology."},{"issue":"7140","key":"243_CR51","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0140-6736(60)92665-9","volume":"2","author":"V Dubowitz","year":"1960","unstructured":"Dubowitz V, Pearse AG. Oxidative enzymes and phosphorylase in central-core disease of muscle. Lancet (London, England). 1960;2(7140):23\u20134.","journal-title":"Lancet (London, England)"},{"key":"243_CR52","volume-title":"Pathology of skeletal muscle","author":"SKG Carpenter","year":"2001","unstructured":"Carpenter SKG. Pathology of skeletal muscle. 2nd ed. New York: Oxford University Press; 2001.","edition":"2"},{"key":"243_CR53","first-page":"282","volume-title":"Disorders of voluntary muscle","author":"W-P CLN","year":"2010","unstructured":"CLN W-P. The congenital myopathies. In: GHJD K, Bushby K, Griggs R, editors. Disorders of voluntary muscle. 8th ed. New York: Cambridge University Press; 2010. p. 282\u201398.","edition":"8"},{"key":"243_CR54","first-page":"1786","volume-title":"Greenfield\u2019s neuropathology","author":"CAJ-MC Sewry","year":"2008","unstructured":"Sewry CAJ-MC, Brown SC, Muntoni F. Disease of muscle. In: SLD L, Ellison D, editors. Greenfield\u2019s neuropathology. 8th ed. London: Hodder Arnold; 2008. p. 1786\u201391.","edition":"8"},{"key":"243_CR55","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/B978-0-12-410529-4.00093-0","volume-title":"Rosenberg\u2019s molecular and genetic basis of neurological and psychiatric disease","author":"HSC Jungbluth","year":"2015","unstructured":"Jungbluth HSC, Muntoni F. The congenital myopathies. In: Rosenberg RNPJ, editor. Rosenberg\u2019s molecular and genetic basis of neurological and psychiatric disease. 5th ed. Massachusetts: Academic Press; 2015. p. 1121\u20138.","edition":"5"},{"issue":"Pt 6","key":"243_CR56","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1093\/brain\/awl077","volume":"129","author":"S Wu","year":"2006","unstructured":"Wu S, Ibarra MC, Malicdan MC, Murayama K, Ichihara Y, Kikuchi H, et al. Central core disease is due to RYR1 mutations in more than 90% of patients. Brain. 2006;129(Pt 6):1470\u201380.","journal-title":"Brain."},{"issue":"6","key":"243_CR57","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.nmd.2010.03.015","volume":"20","author":"V Tosch","year":"2010","unstructured":"Tosch V, Vasli N, Kretz C, Nicot AS, Gasnier C, Dondaine N, et al. Novel molecular diagnostic approaches for X-linked centronuclear (myotubular) myopathy reveal intronic mutations. Neuromuscul Disord. 2010;20(6):375\u201381.","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"243_CR58","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/humu.21157","volume":"31","author":"MW Lawlor","year":"2010","unstructured":"Lawlor MW, Dechene ET, Roumm E, Geggel AS, Moghadaszadeh B, Beggs AH. Mutations of tropomyosin 3 (TPM3) are common and associated with type 1 myofiber hypotrophy in congenital fiber type disproportion. Hum Mutat. 2010;31(2):176\u201383.","journal-title":"Hum Mutat"},{"issue":"7","key":"243_CR59","doi-asserted-by":"publisher","first-page":"E1544","DOI":"10.1002\/humu.21278","volume":"31","author":"NF Clarke","year":"2010","unstructured":"Clarke NF, Waddell LB, Cooper ST, Perry M, Smith RLL, Kornberg AJ, et al. Recessive mutations in RYR1 are a common cause of congenital fiber type disproportion. Hum Mutat. 2010;31(7):E1544\u2013E50.","journal-title":"Hum Mutat"},{"issue":"4","key":"243_CR60","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1086\/342719","volume":"71","author":"A Ferreiro","year":"2002","unstructured":"Ferreiro A, Quijano-Roy S, Pichereau C, Moghadaszadeh B, Goemans N, B\u00f6nnemann C, et al. Mutations of the selenoprotein N gene, which is implicated in rigid spine muscular dystrophy, cause the classical phenotype of multiminicore disease: reassessing the nosology of early-onset myopathies. Am J Hum Genet. 2002;71(4):739\u201349.","journal-title":"Am J Hum Genet"},{"issue":"11","key":"243_CR61","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.nmd.2004.07.007","volume":"14","author":"H Jungbluth","year":"2004","unstructured":"Jungbluth H, Beggs A, Bonnemann C, Bushby K, Ceuterick-de Groote C, Estournet-Mathiaud B, et al. 111th ENMC international workshop on multi-minicore disease. 2nd international MmD workshop, 9-11 November 2002, Naarden, the Netherlands. Neuromuscul Disord. 2004;14(11):754\u201366.","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"243_CR62","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1159\/000221507","volume":"8","author":"H Oppenheim","year":"1900","unstructured":"Oppenheim H. Ueber allgemeine und localisierte Atonie der Muskulatur (Myatonie) im fr\u00fchen Kindesalter. Eur Neurol. 1900;8(3):232\u20133.","journal-title":"Eur Neurol"},{"issue":"2","key":"243_CR63","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/BF01776636","volume":"22","author":"G Werdnig","year":"1891","unstructured":"Werdnig G. Zwei fr\u00fchinfantile heredit\u00e4re F\u00e4lle von progressiver Muskelatrophie unter dem Bilde der Dystrophie, aber anf neurotischer Grundlage. Archiv f\u00fcr Psychiatrie und Nervenkrankheiten. 1891;22(2):437\u201380.","journal-title":"Archiv f\u00fcr Psychiatrie und Nervenkrankheiten"},{"issue":"3-4","key":"243_CR64","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1093\/brain\/50.3-4.652","volume":"50","author":"JG Greenfield","year":"1927","unstructured":"Greenfield JG, Stern RO. The anatomical identity of the Werdnig-Hoffmann and Oppenheim forms of infantile muscular atrophy. Brain. 1927;50(3-4):652\u201386.","journal-title":"Brain."},{"issue":"3","key":"243_CR65","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1001\/archpedi.1931.01940090108011","volume":"41","author":"CR Tuthill","year":"1931","unstructured":"Tuthill CR, Levy MG. Amyotonia: report of a case with histologic observations. Am J Dis Child. 1931;41(3):591\u2013602.","journal-title":"Am J Dis Child"},{"issue":"89","key":"243_CR66","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1136\/adc.17.89.30","volume":"17","author":"JG Macleod","year":"1942","unstructured":"Macleod JG, Macdonald RM. Infantile muscular atrophy of spinal origin: a report of two cases. Arch Dis Child. 1942;17(89):30\u201340.","journal-title":"Arch Dis Child"},{"key":"243_CR67","first-page":"1685","volume":"35","author":"AB Johnson","year":"1900","unstructured":"Johnson AB. Heat-stroke as a post operative complication. JAMA. 1900;35:1685.","journal-title":"JAMA."},{"key":"243_CR68","first-page":"1685","volume":"35","author":"GE Brewer","year":"1900","unstructured":"Brewer GE. Heat-stroke as a post operative complication, abstract of new York academy of medicine-surgical section (Nov. 12, 1990). JAMA. 1900;35:1685.","journal-title":"JAMA."},{"key":"243_CR69","first-page":"1685","volume":"35","author":"C Gibson","year":"1900","unstructured":"Gibson C. Heat-stroke as a post operative complication. JAMA. 1900;35:1685.","journal-title":"JAMA."},{"key":"243_CR70","first-page":"1685","volume":"35","author":"JPT Tuttle","year":"1900","unstructured":"Tuttle JPT. Heat-stroke as a post operative complication. JAMA. 1900;35:1685.","journal-title":"JAMA."},{"key":"243_CR71","first-page":"1685","volume":"35","author":"AV Moschcowitz","year":"1900","unstructured":"Moschcowitz AV. Heat-stroke as a post operative complication. JAMA. 1900;35:1685.","journal-title":"JAMA."},{"issue":"1","key":"243_CR72","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1365-2044.1992.tb01956.x","volume":"47","author":"GG Harrison","year":"1992","unstructured":"Harrison GG, Isaacs H. Malignant hyperthermia. An historical vignette. Anaesthesia. 1992;47(1):54\u20136.","journal-title":"Anaesthesia."},{"key":"243_CR73","unstructured":"Ludvigsen J. UndersGgelser over den sikaldte \u201cmuskeldegeneration\u201d 110 s svin I. 272. beretning jra jorspigslaboratoriet. Statens husdyrbrugsudvalg, K@benhav. 1954."},{"key":"243_CR74","volume-title":"5th European Conj Meat Research Paper 16","author":"EJ Briskey","year":"1959","unstructured":"Briskey EJ. Pre-slaughter treatments as related to post-mortem changes in pork muscle. In: 5th European Conj Meat Research Paper 16; 1959."},{"issue":"2","key":"243_CR75","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1042\/bj0870351","volume":"87","author":"O Kjolberg","year":"1963","unstructured":"Kjolberg O, Manners DJ, Lawrie RA. Alpha-(1-4)-Glucosans. 16. The molecular structure of some pig-muscle glycogens. Biochem J. 1963;87(2):351\u20133.","journal-title":"Biochem J"},{"issue":"4","key":"243_CR76","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1530\/acta.0.0260406","volume":"26","author":"J Ludvigsen","year":"1957","unstructured":"Ludvigsen J. On the hormonal regulation of vasomotor reactions during exercise with special reference to the action of adrenal cortical steroids. Acta Endocrinol. 1957;26(4):406\u201316.","journal-title":"Acta Endocrinol"},{"key":"243_CR77","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0065-2628(08)60100-7","volume":"13","author":"EJ Briskey","year":"1964","unstructured":"Briskey EJ. Etiological status and associated studies of pale, soft, exudative porcine musculature. Adv Food Res. 1964;13:89\u2013178.","journal-title":"Adv Food Res"},{"issue":"1","key":"243_CR78","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1152\/jappl.1968.24.1.33","volume":"24","author":"JC Forrest","year":"1968","unstructured":"Forrest JC, Will JA, Schmidt GR, Judge MD, Briskey EJ. Homeostasisin animals (Sus domesticus) during exposure to a warm environment. J Appl Physiol. 1968;24(1):33\u20139.","journal-title":"J Appl Physiol"},{"issue":"4","key":"243_CR79","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1093\/brain\/81.4.461","volume":"81","author":"JGCT Greenfield","year":"1958","unstructured":"Greenfield JGCT, Shy GM. The prognostic value of the muscle biopsy in the floppy infant. Brain. 1958;81(4):461\u201384.","journal-title":"Brain"},{"key":"243_CR80","doi-asserted-by":"crossref","unstructured":"Denborough MA, Lovell R. Anesthetic deaths in a family. Lancet (London, England). 1960;2(45).","DOI":"10.1016\/S0140-6736(60)92690-8"},{"key":"243_CR81","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1093\/bja\/34.6.395","volume":"34","author":"MA Denborough","year":"1962","unstructured":"Denborough MA, Forster JF, Lovell RR, Maplestone PA, Villiers JD. Anaesthetic deaths in a family. Br J Anaesth. 1962;34:395\u20136.","journal-title":"Br J Anaesth"},{"key":"243_CR82","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1093\/brain\/86.4.793","volume":"86","author":"GM Shy","year":"1963","unstructured":"Shy GM, Engel WK, Somers JE, Wanko T. Nemaline myopathy. A new congenital myopathy. Brain. 1963;86:793\u2013810.","journal-title":"Brain"},{"key":"243_CR83","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1212\/WNL.15.4.371","volume":"15","author":"AK Afifi","year":"1965","unstructured":"Afifi AK, Smith JW, Zellweger H. Congenital nonprogressive myopathy. Central core disease and Nemaline myopathy in one family. Neurology. 1965;15:371\u201381.","journal-title":"Neurology."},{"issue":"1","key":"243_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/archneur.1966.00470070005001","volume":"14","author":"AJ Spiro","year":"1966","unstructured":"Spiro AJ, Shy GM, Gonatas NK. Myotubular myopathy. Persistence of fetal muscle in an adolescent boy. Arch Neurol. 1966;14(1):1\u201314.","journal-title":"Arch Neurol"},{"issue":"8 Pt 1","key":"243_CR85","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1212\/WNL.17.8.727","volume":"17","author":"JH Sher","year":"1967","unstructured":"Sher JH, Rimalovski AB, Athanassiades TJ, Aronson SM. Familial centronuclear myopathy: a clinical and pathological study. Neurology. 1967;17(8 Pt 1):727\u201342.","journal-title":"Neurology."},{"issue":"6","key":"243_CR86","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1212\/WNL.19.6.591","volume":"19","author":"MH Brooke","year":"1969","unstructured":"Brooke MH, Engel WK. The histographic analysis of human muscle biopsies with regard to fiber types. 4. Children's biopsies. Neurology. 1969;19(6):591\u2013605.","journal-title":"Neurology."},{"key":"243_CR87","unstructured":"Brooke M. Clinical studies in myology. Proceedings of the 2nd International Congress on Muscle Diseases. Congenit Fiber-Type Disproportion. 1973:147\u201359."},{"issue":"5-6","key":"243_CR88","first-page":"335","volume":"76","author":"JJ Martin","year":"1976","unstructured":"Martin JJ, Clara R, Ceuterick C. Joris C. Is congenital fibre type disproportion a true myopathy? Acta Neurol Belg. 1976;76(5-6):335\u201344.","journal-title":"Acta Neurol Belg"},{"issue":"10","key":"243_CR89","first-page":"666","volume":"46","author":"AG Engel","year":"1971","unstructured":"Engel AG, Gomez MR, Groover RV. Multicore disease. A recently recognized congenital myopathy associated with multifocal degeneration of muscle fibers. Mayo Clin Proc. 1971;46(10):666\u201381.","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"243_CR90","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/0006-291X(85)91699-7","volume":"128","author":"IN Pessah","year":"1985","unstructured":"Pessah IN, Waterhouse AL, Casida JE. The calcium-ryanodine receptor complex of skeletal and cardiac muscle. Biochem Biophys Res Commun. 1985;128(1):449\u201356.","journal-title":"Biochem Biophys Res Commun"},{"issue":"21","key":"243_CR91","doi-asserted-by":"publisher","first-page":"7256","DOI":"10.1073\/pnas.82.21.7256","volume":"82","author":"S Fleischer","year":"1985","unstructured":"Fleischer S, Ogunbunmi EM, Dixon MC, Fleer EA. Localization of Ca2+ release channels with ryanodine in junctional terminal cisternae of sarcoplasmic reticulum of fast skeletal muscle. Proc Natl Acad Sci U S A. 1985;82(21):7256\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"243_CR92","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/BF00396370","volume":"11","author":"PJ O'Brien","year":"1987","unstructured":"O'Brien PJ. Etiopathogenetic defect of malignant hyperthermia: hypersensitive calcium-release channel of skeletal muscle sarcoplasmic reticulum. Vet Res Commun. 1987;11(6):527\u201359.","journal-title":"Vet Res Commun"},{"issue":"3","key":"243_CR93","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/j.1365-2052.1988.tb00809.x","volume":"19","author":"W Davies","year":"1988","unstructured":"Davies W, Harbitz I, Fries R, Stranzinger G, Hauge JG. Porcine malignant hyperthermia carrier detection and chromosomal assignment using a linked probe. Anim Genet. 1988;19(3):203\u201312.","journal-title":"Anim Genet"},{"key":"243_CR94","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-94-009-3301-9_1","volume-title":"Evaluation and control of meat quality in pigs: a seminar in the CEC agricultural research Programme, held in Dublin, Ireland, 21-22 November 1985","author":"D Lister","year":"1987","unstructured":"Lister D. The physiology and biochemistry of the porcine stress syndrome. In: Tarrant PV, Eikelenboom G, Monin G, editors. Evaluation and control of meat quality in pigs: a seminar in the CEC agricultural research Programme, held in Dublin, Ireland, 21-22 November 1985. Dordrecht: Springer Netherlands; 1987. p. 3\u201316."},{"issue":"6027","key":"243_CR95","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/316446a0","volume":"316","author":"JS Smith","year":"1985","unstructured":"Smith JS, Coronado R, Meissner G. Sarcoplasmic reticulum contains adenine nucleotide-activated calcium channels. Nature. 1985;316(6027):446\u20139.","journal-title":"Nature."},{"issue":"14","key":"243_CR96","doi-asserted-by":"crossref","first-page":"6300","DOI":"10.1016\/S0021-9258(19)84563-5","volume":"261","author":"G Meissner","year":"1986","unstructured":"Meissner G. Ryanodine activation and inhibition of the Ca2+ release channel of sarcoplasmic reticulum. J Biol Chem. 1986;261(14):6300\u20136.","journal-title":"J Biol Chem"},{"issue":"34","key":"243_CR97","doi-asserted-by":"crossref","first-page":"16636","DOI":"10.1016\/S0021-9258(18)49303-9","volume":"262","author":"T Imagawa","year":"1987","unstructured":"Imagawa T, Smith JS, Coronado R, Campbell KP. Purified ryanodine receptor from skeletal muscle sarcoplasmic reticulum is the Ca2 + -permeable pore of the calcium release channel. J Biol Chem. 1987;262(34):16636\u201343.","journal-title":"J Biol Chem"},{"issue":"4","key":"243_CR98","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/S0021-9258(19)75701-9","volume":"262","author":"M Inui","year":"1987","unstructured":"Inui M, Saito A, Fleischer S. Purification of the ryanodine receptor and identity with feet structures of junctional terminal cisternae of sarcoplasmic reticulum from fast skeletal muscle. J Biol Chem. 1987;262(4):1740\u20137.","journal-title":"J Biol Chem"},{"issue":"4","key":"243_CR99","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1016\/S0021-9258(19)39968-5","volume":"265","author":"F Zorzato","year":"1990","unstructured":"Zorzato F, Fujii J, Otsu K, Phillips M, Green NM, Lai FA, et al. Molecular cloning of cDNA encoding human and rabbit forms of the Ca2+ release channel (ryanodine receptor) of skeletal muscle sarcoplasmic reticulum. J Biol Chem. 1990;265(4):2244\u201356.","journal-title":"J Biol Chem"},{"issue":"6224","key":"243_CR100","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/339439a0","volume":"339","author":"H Takeshima","year":"1989","unstructured":"Takeshima H, Nishimura S, Matsumoto T, Ishida H, Kangawa K, Minamino N, et al. Primary structure and expression from complementary DNA of skeletal muscle ryanodine receptor. Nature. 1989;339(6224):439\u201345.","journal-title":"Nature."},{"issue":"22","key":"243_CR101","doi-asserted-by":"publisher","first-page":"8683","DOI":"10.1073\/pnas.86.22.8683","volume":"86","author":"AR Marks","year":"1989","unstructured":"Marks AR, Tempst P, Hwang KS, Taubman MB, Inui M, Chadwick C, et al. Molecular cloning and characterization of the ryanodine receptor\/junctional channel complex cDNA from skeletal muscle sarcoplasmic reticulum. Proc Natl Acad Sci U S A. 1989;86(22):8683\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"243_CR102","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/0022-510X(88)90109-8","volume":"86","author":"J Walton","year":"1988","unstructured":"Walton J, Thomas PK. Classification of neuromuscular diseases. J Neurol Sci. 1988;86(2):333\u201360.","journal-title":"J Neurol Sci"},{"issue":"6258","key":"243_CR103","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/343559a0","volume":"343","author":"DH MacLennan","year":"1990","unstructured":"MacLennan DH, Duff C, Zorzato F, Fujii J, Phillips M, Korneluk RG, et al. Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia. Nature. 1990;343(6258):559\u201361.","journal-title":"Nature."},{"issue":"4","key":"243_CR104","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/0888-7543(92)90042-Q","volume":"13","author":"EF Gillard","year":"1992","unstructured":"Gillard EF, Otsu K, Fujii J, Duff C, de Leon S, Khanna VK, et al. Polymorphisms and deduced amino acid substitutions in the coding sequence of the ryanodine receptor (RYR1) gene in individuals with malignant hyperthermia. Genomics. 1992;13(4):1247\u201354.","journal-title":"Genomics."},{"issue":"1","key":"243_CR105","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/ng0993-51","volume":"5","author":"KA Quane","year":"1993","unstructured":"Quane KA, Healy JM, Keating KE, Manning BM, Couch FJ, Palmucci LM, et al. Mutations in the ryanodine receptor gene in central core disease and malignant hyperthermia. Nat Genet. 1993;5(1):51\u20135.","journal-title":"Nat Genet"},{"issue":"14","key":"243_CR106","doi-asserted-by":"publisher","first-page":"e1600","DOI":"10.1212\/WNL.0000000000007246","volume":"92","author":"M Jokela","year":"2019","unstructured":"Jokela M, Tasca G, Vihola A, Mercuri E, Jonson PH, Lehtinen S, et al. An unusual ryanodine receptor 1 (RYR1) phenotype: mild calf-predominant myopathy. Neurology. 2019;92(14):e1600\u2013e9.","journal-title":"Neurology."},{"issue":"12","key":"243_CR107","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.nmd.2004.08.006","volume":"14","author":"H Jungbluth","year":"2004","unstructured":"Jungbluth H, Davis MR, Muller C, Counsell S, Allsop J, Chattopadhyay A, et al. Magnetic resonance imaging of muscle in congenital myopathies associated with RYR1 mutations. Neuromuscul Disord. 2004;14(12):785\u201390.","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"243_CR108","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1096\/fj.05-4497fje","volume":"20","author":"MG Chelu","year":"2006","unstructured":"Chelu MG, Goonasekera SA, Durham WJ, Tang W, Lueck JD, Riehl J, et al. Heat- and anesthesia-induced malignant hyperthermia in an RyR1 knock-in mouse. FASEB J. 2006;20(2):329\u201330.","journal-title":"FASEB J"},{"issue":"6","key":"243_CR109","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1097\/00000542-200612000-00016","volume":"105","author":"T Yang","year":"2006","unstructured":"Yang T, Riehl J, Esteve E, Matthaei KI, Goth S, Allen PD, et al. Pharmacologic and functional characterization of malignant hyperthermia in the R163C RyR1 knock-in mouse. Anesthesiology. 2006;105(6):1164\u201375.","journal-title":"Anesthesiology."},{"issue":"18","key":"243_CR110","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1093\/hmg\/9.18.2599","volume":"9","author":"N Monnier","year":"2000","unstructured":"Monnier N, Romero NB, Lerale J, Nivoche Y, Qi D, MacLennan DH, et al. An autosomal dominant congenital myopathy with cores and rods is associated with a neomutation in the RYR1 gene encoding the skeletal muscle ryanodine receptor. Hum Mol Genet. 2000;9(18):2599\u2013608.","journal-title":"Hum Mol Genet"},{"issue":"5","key":"243_CR111","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.nmd.2011.12.003","volume":"22","author":"H Jungbluth","year":"2012","unstructured":"Jungbluth H, Dowling JJ, Ferreiro A, Muntoni F. 182nd ENMC international workshop: RYR1-related myopathies, 15-17th April 2011, Naarden, the Netherlands. Neuromuscul Disord. 2012;22(5):453\u201362.","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"243_CR112","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3233\/JND-180376","volume":"6","author":"D Westra","year":"2019","unstructured":"Westra D, Schouten MI, Stunnenberg BC, Kusters B, Saris CGJ, Erasmus CE, et al. Panel-based exome sequencing for neuromuscular disorders as a diagnostic service. J Neuromusc Dis. 2019;6(2):241\u201358.","journal-title":"J Neuromusc Dis"},{"key":"243_CR113","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3389\/fnagi.2014.00267","volume":"6","author":"J Palmio","year":"2014","unstructured":"Palmio J, Udd B. Borderlines between sarcopenia and mild late-onset muscle disease. Front Aging Neurosci. 2014;6:267.","journal-title":"Front Aging Neurosci"},{"issue":"7532","key":"243_CR114","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nature13950","volume":"517","author":"R Zalk","year":"2015","unstructured":"Zalk R, Clarke OB, Des Georges A, Grassucci RA, Reiken S, Mancia F, et al. Structure of a mammalian ryanodine receptor. Nature. 2015;517(7532):44\u20139.","journal-title":"Nature."},{"issue":"11","key":"243_CR115","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/j.str.2009.08.016","volume":"17","author":"PA Lobo","year":"2009","unstructured":"Lobo PA, Van Petegem F. Crystal structures of the N-terminal domains of cardiac and skeletal muscle ryanodine receptors: insights into disease mutations. Structure (London, England : 1993). 2009;17(11):1505\u201314.","journal-title":"Structure (London, England : 1993)"},{"issue":"7532","key":"243_CR116","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature14063","volume":"517","author":"Z Yan","year":"2015","unstructured":"Yan Z, Bai X, Yan C, Wu J, Li Z, Xie T, et al. Structure of the rabbit ryanodine receptor RyR1 at near-atomic resolution. Nature. 2015;517(7532):50\u20135.","journal-title":"Nature."},{"issue":"7532","key":"243_CR117","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/nature13916","volume":"517","author":"RG Efremov","year":"2015","unstructured":"Efremov RG, Leitner A, Aebersold R, Raunser S. Architecture and conformational switch mechanism of the ryanodine receptor. Nature. 2015;517(7532):39\u201343.","journal-title":"Nature."},{"issue":"1","key":"243_CR118","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.cell.2016.08.075","volume":"167","author":"A Desgeorges","year":"2016","unstructured":"Desgeorges A, Clarke OB, Zalk R, Yuan Q, Condon KJ, Grassucci RA, et al. Structural basis for gating and activation of RyR1. Cell. 2016;167(1):145\u201357.e17.","journal-title":"Cell"},{"issue":"1","key":"243_CR119","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/pro.3052","volume":"26","author":"M Samso","year":"2017","unstructured":"Samso M. A guide to the 3D structure of the ryanodine receptor type 1 by cryoEM. Protein Sci. 2017;26(1):52\u201368.","journal-title":"Protein Sci"},{"issue":"5","key":"243_CR120","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1055\/s-2004-821173","volume":"35","author":"S Messina","year":"2004","unstructured":"Messina S, Hartley L, Main M, Kinali M, Jungbluth H, Muntoni F, et al. Pilot trial of salbutamol in central core and multi-minicore diseases. Neuropediatrics. 2004;35(5):262\u20136.","journal-title":"Neuropediatrics."},{"issue":"13","key":"243_CR121","doi-asserted-by":"publisher","first-page":"e1434","DOI":"10.1212\/WNL.0000000000008872","volume":"94","author":"JJ Todd","year":"2020","unstructured":"Todd JJ, Lawal TA, Witherspoon JW, Chrismer IC, Razaqyar MS, Punjabi M, et al. Randomized controlled trial of N-acetylcysteine therapy for RYR1-related myopathies. Neurology. 2020;94(13):e1434\u2013e44.","journal-title":"Neurology."},{"issue":"1","key":"243_CR122","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.cell.2008.02.042","volume":"133","author":"WJ Durham","year":"2008","unstructured":"Durham WJ, Aracena-Parks P, Long C, Rossi AE, Goonasekera SA, Boncompagni S, et al. RyR1 S-nitrosylation underlies environmental heat stroke and sudden death in Y522S RyR1 knockin mice. Cell. 2008;133(1):53\u201365.","journal-title":"Cell."},{"issue":"15","key":"243_CR123","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1242\/dev.004531","volume":"134","author":"H Hirata","year":"2007","unstructured":"Hirata H, Watanabe T, Hatakeyama J, Sprague SM, Saint-Amant L, Nagashima A, et al. Zebrafish relatively relaxed mutants have a ryanodine receptor defect, show slow swimming and provide a model of multi-minicore disease. Development (Cambridge, England). 2007;134(15):2771\u201381.","journal-title":"Development (Cambridge, England)"},{"issue":"Pt 4","key":"243_CR124","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1093\/brain\/aws036","volume":"135","author":"JJ Dowling","year":"2012","unstructured":"Dowling JJ, Arbogast S, Hur J, Nelson DD, McEvoy A, Waugh T, et al. Oxidative stress and successful antioxidant treatment in models of RYR1-related myopathy. Brain. 2012;135(Pt 4):1115\u201327.","journal-title":"Brain."},{"key":"243_CR125","doi-asserted-by":"crossref","unstructured":"Volpatti JR, Endo Y, Knox J, Groom L, Brennan S, Noche R, et al. Identification of drug modifiers for RYR1-related myopathy using a multi-species discovery pipeline. eLife. 2020;9.","DOI":"10.7554\/eLife.52946"},{"issue":"1","key":"243_CR126","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1124\/mol.117.111468","volume":"94","author":"T Murayama","year":"2018","unstructured":"Murayama T, Kurebayashi N, Ishigami-Yuasa M, Mori S, Suzuki Y, Akima R, et al. Efficient high-throughput screening by endoplasmic reticulum ca(2+) measurement to identify inhibitors of ryanodine receptor ca(2+)-release channels. Mol Pharmacol. 2018;94(1):722\u201330.","journal-title":"Mol Pharmacol"},{"issue":"1","key":"243_CR127","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-58461-1","volume":"10","author":"RT Rebbeck","year":"2020","unstructured":"Rebbeck RT, Singh DP, Janicek KA, Bers DM, Thomas DD, Launikonis BS, et al. RyR1-targeted drug discovery pipeline integrating FRET-based high-throughput screening and human myofiber dynamic ca(2+) assays. Sci Rep. 2020;10(1):1791.","journal-title":"Sci Rep"},{"key":"243_CR128","doi-asserted-by":"crossref","unstructured":"Elbaz M, Ruiz A, Bachmann C, Eckhardt J, Pelczar P, Venturi E, et al. Quantitative RyR1 reduction and loss of calcium sensitivity of RyR1Q1970fsX16 + A4329D cause cores and loss of muscle strength. Hum Mol Genet. 2019.","DOI":"10.1093\/hmg\/ddz092"},{"key":"243_CR129","doi-asserted-by":"crossref","unstructured":"Brennan S, Garcia-Castaneda M, Michelucci A, Sabha N, Malik S, Groom L, et al. Mouse model of severe recessive RYR1-related myopathy. Hum Mol Genet. 2019.","DOI":"10.1093\/hmg\/ddz105"},{"key":"243_CR130","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1146\/annurev-genet-120417-031311","volume":"52","author":"R Pancaroglu","year":"2018","unstructured":"Pancaroglu R, Van Petegem F. Calcium channelopathies: structural insights into disorders of the muscle excitation-contraction complex. Annu Rev Genet. 2018;52:373\u201396.","journal-title":"Annu Rev Genet"},{"issue":"10","key":"243_CR131","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/S0960-8966(02)00135-9","volume":"12","author":"CA Sewry","year":"2002","unstructured":"Sewry CA, Muller C, Davis M, Dwyer JS, Dove J, Evans G, et al. The spectrum of pathology in central core disease. Neuromuscul Disord. 2002;12(10):930\u20138.","journal-title":"Neuromuscul Disord"},{"issue":"12","key":"243_CR132","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1136\/adc.88.12.1051","volume":"88","author":"RM Quinlivan","year":"2003","unstructured":"Quinlivan RM, Muller CR, Davis M, Laing NG, Evans GA, Dwyer J, et al. Central core disease: clinical, pathological, and genetic features. Arch Dis Child. 2003;88(12):1051\u20135.","journal-title":"Arch Dis Child"},{"issue":"6","key":"243_CR133","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0960-8966(98)00043-1","volume":"8","author":"PJ Lamont","year":"1998","unstructured":"Lamont PJ, Dubowitz V, Landon DN, Davis M, Morgan-Hughes JA. Fifty year follow-up of a patient with central core disease shows slow but definite progression. Neuromuscul Disord. 1998;8(6):385\u201391.","journal-title":"Neuromuscul Disord"},{"issue":"Pt 11","key":"243_CR134","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1093\/brain\/awg244","volume":"126","author":"NB Romero","year":"2003","unstructured":"Romero NB, Monnier N, Viollet L, Cortey A, Chevallay M, Leroy JP, et al. Dominant and recessive central core disease associated with RYR1 mutations and fetal akinesia. Brain. 2003;126(Pt 11):2341\u20139.","journal-title":"Brain."},{"issue":"5","key":"243_CR135","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.1529\/biophysj.104.048447","volume":"87","author":"RT Dirksen","year":"2004","unstructured":"Dirksen RT, Avila G. Distinct effects on Ca2+ handling caused by malignant hyperthermia and central core disease mutations in RyR1. Biophys J. 2004;87(5):3193\u2013204.","journal-title":"Biophys J"},{"issue":"2","key":"243_CR136","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1074\/jbc.274.2.693","volume":"274","author":"J Tong","year":"1999","unstructured":"Tong J, McCarthy TV, MacLennan DH. Measurement of resting cytosolic Ca2+ concentrations and Ca2+ store size in HEK-293 cells transfected with malignant hyperthermia or central core disease mutant Ca2+ release channels. J Biol Chem. 1999;274(2):693\u2013702.","journal-title":"J Biol Chem"},{"issue":"11","key":"243_CR137","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1136\/jmg.2004.020271","volume":"41","author":"AM Kaindl","year":"2004","unstructured":"Kaindl AM, R\u00fcschendorf F, Krause S, Goebel H-H, Koehler K, Becker C, et al. Missense mutations of ACTA1 cause dominant congenital myopathy with cores. J Med Genet. 2004;41(11):842\u20138.","journal-title":"J Med Genet"},{"issue":"3","key":"243_CR138","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.pmr.2012.06.006","volume":"23","author":"NC Joyce","year":"2012","unstructured":"Joyce NC, Oskarsson B, Jin LW. Muscle biopsy evaluation in neuromuscular disorders. Phys Med Rehabil Clin N Am. 2012;23(3):609\u201331.","journal-title":"Phys Med Rehabil Clin N Am"},{"issue":"6","key":"243_CR139","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1093\/ajcp\/59.6.790","volume":"59","author":"J Kovarsky","year":"1973","unstructured":"Kovarsky J, Schochet SS Jr, McCormick WF. The significance of target fibers: a clinicopathologic review of 100 patients with neurogenic atrophy. Am J Clin Pathol. 1973;59(6):790\u20137.","journal-title":"Am J Clin Pathol"},{"issue":"11","key":"243_CR140","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1212\/WNL.55.11.1689","volume":"55","author":"PC Scacheri","year":"2000","unstructured":"Scacheri PC, Hoffman EP, Fratkin JD, Semino-Mora C, Senchak A, Davis MR, et al. A novel ryanodine receptor gene mutation causing both cores and rods in congenital myopathy. Neurology. 2000;55(11):1689\u201396.","journal-title":"Neurology."},{"issue":"6","key":"243_CR141","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1002\/ana.10231","volume":"51","author":"A Ferreiro","year":"2002","unstructured":"Ferreiro A, Monnier N, Romero NB, Leroy JP, Bonnemann C, Haenggeli CA, et al. A recessive form of central core disease, transiently presenting as multi-minicore disease, is associated with a homozygous mutation in the ryanodine receptor type 1 gene. Ann Neurol. 2002;51(6):750\u20139.","journal-title":"Ann Neurol"},{"issue":"11","key":"243_CR142","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1038\/ejhg.2013.31","volume":"21","author":"M Scoto","year":"2013","unstructured":"Scoto M, Cullup T, Cirak S, Yau S, Manzur AY, Feng L, et al. Nebulin (NEB) mutations in a childhood onset distal myopathy with rods and cores uncovered by next generation sequencing. Eur J Hum Genet. 2013;21(11):1249\u201352.","journal-title":"Eur J Hum Genet"},{"issue":"Pt 7","key":"243_CR143","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1093\/brain\/awg162","volume":"126","author":"IM Gommans","year":"2003","unstructured":"Gommans IM, Davis M, Saar K, Lammens M, Mastaglia F, Lamont P, et al. A locus on chromosome 15q for a dominantly inherited nemaline myopathy with core-like lesions. Brain. 2003;126(Pt 7):1545\u201351.","journal-title":"Brain."},{"issue":"21","key":"243_CR144","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.1093\/hmg\/ddl250","volume":"15","author":"V Tosch","year":"2006","unstructured":"Tosch V, Rohde HM, Tronchere H, Zanoteli E, Monroy N, Kretz C, et al. A novel PtdIns3P and PtdIns(3,5)P2 phosphatase with an inactivating variant in centronuclear myopathy. Hum Mol Genet. 2006;15(21):3098\u2013106.","journal-title":"Hum Mol Genet"},{"issue":"4","key":"243_CR145","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1002\/ajmg.a.35243","volume":"158a","author":"E Kondo","year":"2012","unstructured":"Kondo E, Nishimura T, Kosho T, Inaba Y, Mitsuhashi S, Ishida T, et al. Recessive RYR1 mutations in a patient with severe congenital nemaline myopathy with ophthalomoplegia identified through massively parallel sequencing. Am J Med Genet A. 2012;158a(4):772\u20138.","journal-title":"Am J Med Genet A"},{"issue":"5","key":"243_CR146","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1002\/ana.22119","volume":"68","author":"JM Wilmshurst","year":"2010","unstructured":"Wilmshurst JM, Lillis S, Zhou H, Pillay K, Henderson H, Kress W, et al. RYR1 mutations are a common cause of congenital myopathies with central nuclei. Ann Neurol. 2010;68(5):717\u201326.","journal-title":"Ann Neurol"},{"issue":"2","key":"243_CR147","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1212\/WNL.59.2.284","volume":"59","author":"H Jungbluth","year":"2002","unstructured":"Jungbluth H, Muller CR, Halliger-Keller B, Brockington M, Brown SC, Feng L, et al. Autosomal recessive inheritance of RYR1 mutations in a congenital myopathy with cores. Neurology. 2002;59(2):284\u20137.","journal-title":"Neurology."},{"issue":"4","key":"243_CR148","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.nmd.2010.01.014","volume":"20","author":"NB Romero","year":"2010","unstructured":"Romero NB. Centronuclear myopathies: a widening concept. Neuromuscul Disord. 2010;20(4):223\u20138.","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"243_CR149","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00401-008-0472-1","volume":"117","author":"JA Bevilacqua","year":"2009","unstructured":"Bevilacqua JA, Bitoun M, Biancalana V, Oldfors A, Stoltenburg G, Claeys KG, et al. \"necklace\" fibers, a new histological marker of late-onset MTM1-related centronuclear myopathy. Acta Neuropathol. 2009;117(3):283\u201391.","journal-title":"Acta Neuropathol"},{"issue":"11","key":"243_CR150","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/ng1657","volume":"37","author":"M Bitoun","year":"2005","unstructured":"Bitoun M, Maugenre S, Jeannet PY, Lacene E, Ferrer X, Laforet P, et al. Mutations in dynamin 2 cause dominant centronuclear myopathy. Nat Genet. 2005;37(11):1207\u20139.","journal-title":"Nat Genet"},{"issue":"4","key":"243_CR151","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.spen.2011.10.008","volume":"18","author":"NF Clarke","year":"2011","unstructured":"Clarke NF. Congenital fiber-type disproportion. Semin Pediatr Neurol. 2011;18(4):264\u201371.","journal-title":"Semin Pediatr Neurol"},{"issue":"5","key":"243_CR152","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1097\/00019052-200110000-00005","volume":"14","author":"N Tubridy","year":"2001","unstructured":"Tubridy N, Fontaine B, Eymard B. Congenital myopathies and congenital muscular dystrophies. Curr Opin Neurol. 2001;14(5):575\u201382.","journal-title":"Curr Opin Neurol"},{"issue":"5","key":"243_CR153","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1002\/ana.20260","volume":"56","author":"NG Laing","year":"2004","unstructured":"Laing NG, Clarke NF, Dye DE, Liyanage K, Walker KR, Kobayashi Y, et al. Actin mutations are one cause of congenital fibre type disproportion. Ann Neurol. 2004;56(5):689\u201394.","journal-title":"Ann Neurol"},{"issue":"12","key":"243_CR154","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.nmd.2008.07.007","volume":"18","author":"A Brandis","year":"2008","unstructured":"Brandis A, Aronica E, Goebel HH. TPM2 mutation. Neuromusc Disorders. 2008;18(12):1005.","journal-title":"Neuromusc Disorders"},{"issue":"1","key":"243_CR155","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1001\/archneur.61.1.27","volume":"61","author":"KD Mathews","year":"2004","unstructured":"Mathews KD, Moore SA. Multiminicore myopathy, central core disease, malignant hyperthermia susceptibility, and RYR1 mutations: one disease with many faces? Arch Neurol. 2004;61(1):27\u20139.","journal-title":"Arch Neurol"},{"issue":"12","key":"243_CR156","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1212\/01.wnl.0000188870.37076.f2","volume":"65","author":"H Jungbluth","year":"2005","unstructured":"Jungbluth H, Zhou H, Hartley L, Halliger-Keller B, Messina S, Longman C, et al. Minicore myopathy with ophthalmoplegia caused by mutations in the ryanodine receptor type 1 gene. Neurology. 2005;65(12):1930\u20135.","journal-title":"Neurology."},{"issue":"1","key":"243_CR157","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/S0960-8966(01)00237-1","volume":"12","author":"A Ferreiro","year":"2002","unstructured":"Ferreiro A, Fardeau M. 80th ENMC International Workshop on Multi-Minicore Disease: 1st International MmD Workshop 12\u201313th May, 2000, Soestduinen, The Netherlands. Neuromuscul Disord. 2002;12(1):60\u20138.","journal-title":"Neuromuscul Disord"},{"issue":"12","key":"243_CR158","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.nmd.2012.06.007","volume":"22","author":"T Cullup","year":"2012","unstructured":"Cullup T, Lamont PJ, Cirak S, Damian MS, Wallefeld W, Gooding R, et al. Mutations in MYH7 cause multi-minicore disease (MmD) with variable cardiac involvement. Neuromuscul Disord. 2012;22(12):1096\u2013104.","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"243_CR159","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/ana.21089","volume":"61","author":"V Carmignac","year":"2007","unstructured":"Carmignac V, Salih MA, Quijano-Roy S, Marchand S, Al Rayess MM, Mukhtar MM, et al. C-terminal titin deletions cause a novel early-onset myopathy with fatal cardiomyopathy. Ann Neurol. 2007;61(4):340\u201351.","journal-title":"Ann Neurol"},{"key":"243_CR160","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-2-31","volume":"2","author":"H Jungbluth","year":"2007","unstructured":"Jungbluth H. Multi-minicore disease. Orphanet J Rare Dis. 2007;2:31.","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"243_CR161","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1002\/ana.20077","volume":"55","author":"A Ferreiro","year":"2004","unstructured":"Ferreiro A, Ceuterick-de Groote C, Marks JJ, Goemans N, Schreiber G, Hanefeld F, et al. Desmin-related myopathy with Mallory body-like inclusions is caused by mutations of the selenoprotein N gene. Ann Neurol. 2004;55(5):676\u201386.","journal-title":"Ann Neurol"},{"issue":"2","key":"243_CR162","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s11910-012-0255-x","volume":"12","author":"JR Nance","year":"2012","unstructured":"Nance JR, Dowling JJ, Gibbs EM, Bonnemann CG. Congenital myopathies: an update. Curr Neurol Neurosci Rep. 2012;12(2):165\u201374.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"24","key":"243_CR163","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1212\/WNL.0b013e31821f467c","volume":"76","author":"M Scoto","year":"2011","unstructured":"Scoto M, Cirak S, Mein R, Feng L, Manzur AY, Robb S, et al. SEPN1-related myopathies: clinical course in a large cohort of patients. Neurology. 2011;76(24):2073\u20138.","journal-title":"Neurology."},{"issue":"2","key":"243_CR164","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/ana.21846","volume":"67","author":"E Mercuri","year":"2010","unstructured":"Mercuri E, Clements E, Offiah A, Pichiecchio A, Vasco G, Bianco F, et al. Muscle magnetic resonance imaging involvement in muscular dystrophies with rigidity of the spine. Ann Neurol. 2010;67(2):201\u20138.","journal-title":"Ann Neurol"},{"issue":"12","key":"243_CR165","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1007\/BF02072073","volume":"149","author":"E Bertini","year":"1990","unstructured":"Bertini E, Bosman C, Bevilacqua M, Ricci E, Gagliardi GM, Parisi F, et al. Cardiomyopathy and multicore myopathy with accumulation of intermediate filaments. Eur J Pediatr. 1990;149(12):856\u20138.","journal-title":"Eur J Pediatr"},{"issue":"17","key":"243_CR166","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1462399402004842","volume":"4","author":"SL Maidment","year":"2002","unstructured":"Maidment SL, Ellis JA. Muscular dystrophies, dilated cardiomyopathy, lipodystrophy and neuropathy: the nuclear connection. Expert Rev Mol Med. 2002;4(17):1\u201321.","journal-title":"Expert Rev Mol Med"},{"issue":"1","key":"243_CR167","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00415-009-0105-1","volume":"256","author":"NC Voermans","year":"2009","unstructured":"Voermans NC, Bonnemann CG, Hamel BCJ, Jungbluth H, van Engelen BG. Joint hypermobility as a distinctive feature in the differential diagnosis of myopathies. J Neurol. 2009;256(1):13\u201327.","journal-title":"J Neurol"},{"issue":"4","key":"243_CR168","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.nmd.2007.01.016","volume":"17","author":"H Jungbluth","year":"2007","unstructured":"Jungbluth H, Zhou H, Sewry CA, Robb S, Treves S, Bitoun M, et al. Centronuclear myopathy due to a de novo dominant mutation in the skeletal muscle ryanodine receptor (RYR1) gene. Neuromuscul Disord. 2007;17(4):338\u201345.","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"243_CR169","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0960-8966(00)00167-X","volume":"11","author":"H Jungbluth","year":"2001","unstructured":"Jungbluth H, Sewry CA, Brown SC, Nowak KJ, Laing NG, Wallgren-Pettersson C, et al. Mild phenotype of nemaline myopathy with sleep hypoventilation due to a mutation in the skeletal muscle alpha-actin (ACTA1) gene. Neuromuscul Disord. 2001;11(1):35\u201340.","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"243_CR170","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1086\/510402","volume":"80","author":"PB Agrawal","year":"2007","unstructured":"Agrawal PB, Greenleaf RS, Tomczak KK, Lehtokari V-L, Wallgren-Pettersson C, Wallefeld W, et al. Nemaline myopathy with minicores caused by mutation of the CFL2 gene encoding the skeletal muscle actin-binding protein, cofilin-2. Am J Hum Genet. 2007;80(1):162\u20137.","journal-title":"Am J Hum Genet"},{"key":"243_CR171","doi-asserted-by":"crossref","unstructured":"Kinali MBD, Pitt MC, Jungbluth H, Simonds AK, Aloysius A, et al. Congenital myasthenic syndromes in childhood: diagnostic and management challenges. J Neuroimmunol. 2008:6\u201312.","DOI":"10.1016\/j.jneuroim.2008.06.026"},{"issue":"4","key":"243_CR172","doi-asserted-by":"crossref","first-page":"398","DOI":"10.4103\/0972-2327.165455","volume":"18","author":"I Pant","year":"2015","unstructured":"Pant I, Chaturvedi S, Bala K, Kushwaha S. Muscle histopathology in today's era of molecular genetics: role and limitations. Ann Indian Acad Neurol. 2015;18(4):398\u2013402.","journal-title":"Ann Indian Acad Neurol"},{"key":"243_CR173","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-2-25","volume":"2","author":"H Jungbluth","year":"2007","unstructured":"Jungbluth H. Central core disease. Orphanet J Rare Dis. 2007;2:25.","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"243_CR174","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1002\/mus.20715","volume":"35","author":"PM Kossugue","year":"2007","unstructured":"Kossugue PM, Paim JF, Navarro MM, Silva HC, Pavanello RC, Gurgel-Giannetti J, et al. Central core disease due to recessive mutations in RYR1 gene: is it more common than described? Muscle Nerve. 2007;35(5):670\u20134.","journal-title":"Muscle Nerve"},{"issue":"1","key":"243_CR175","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/mus.22009","volume":"44","author":"ST Duarte","year":"2011","unstructured":"Duarte ST, Oliveira J, Santos R, Pereira P, Barroso C, Conceicao I, et al. Dominant and recessive RYR1 mutations in adults with core lesions and mild muscle symptoms. Muscle Nerve. 2011;44(1):102\u20138.","journal-title":"Muscle Nerve"},{"issue":"1","key":"243_CR176","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/ALN.0000000000001877","volume":"128","author":"RS Litman","year":"2018","unstructured":"Litman RS, Griggs SM, Dowling JJ, Riazi S. Malignant hyperthermia susceptibility and related diseases. Anesthesiology. 2018;128(1):159\u201367.","journal-title":"Anesthesiology."},{"issue":"1","key":"243_CR177","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2253-14-S1-A13","volume":"14","author":"D Fiszer","year":"2014","unstructured":"Fiszer D, Fisher NA, Carr IM, Shaw M-A, Hopkins PM. Advantage from massive parallel sequencing of RYR1 and CACNA1S in diagnostics of malignant hyperthermia susceptibility. BMC Anesthesiol. 2014;14(1):A13.","journal-title":"BMC Anesthesiol"},{"issue":"1","key":"243_CR178","doi-asserted-by":"publisher","DOI":"10.1186\/s13052-017-0419-z","volume":"43","author":"D Cassandrini","year":"2017","unstructured":"Cassandrini D, Trovato R, Rubegni A, Lenzi S, Fiorillo C, Baldacci J, et al. Congenital myopathies: clinical phenotypes and new diagnostic tools. Ital J Pediatr. 2017;43(1):101.","journal-title":"Ital J Pediatr"},{"key":"243_CR179","doi-asserted-by":"crossref","unstructured":"Todd JJ, Sagar V, Lawal TA, Allen C, Razaqyar MS, Shelton MS, et al. Correlation of phenotype with genotype and protein structure in RYR1-related disorders. J Neurol. 2018.","DOI":"10.1007\/s00415-018-9033-2"},{"issue":"6","key":"243_CR180","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/jhg.2016.2","volume":"61","author":"J Oliveira","year":"2016","unstructured":"Oliveira J, Goncalves A, Taipa R, Melo-Pires M, Oliveira ME, Costa JL, et al. New massive parallel sequencing approach improves the genetic characterization of congenital myopathies. J Hum Genet. 2016;61(6):497\u2013505.","journal-title":"J Hum Genet"},{"issue":"3","key":"243_CR181","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.pmr.2012.06.002","volume":"23","author":"WD Arnold","year":"2012","unstructured":"Arnold WD. Flanigan KM. A practical approach to molecular diagnostic testing in neuromuscular diseases. Phys Med Rehabil Clin N Am. 2012;23(3):589\u2013608.","journal-title":"Phys Med Rehabil Clin N Am"},{"issue":"3","key":"243_CR182","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.pmr.2012.06.011","volume":"23","author":"CM McDonald","year":"2012","unstructured":"McDonald CM. Clinical approach to the diagnostic evaluation of hereditary and acquired neuromuscular diseases. Phys Med Rehabil Clin N Am. 2012;23(3):495\u2013563.","journal-title":"Phys Med Rehabil Clin N Am"},{"issue":"49","key":"243_CR183","doi-asserted-by":"publisher","first-page":"38453","DOI":"10.1074\/jbc.M110.164525","volume":"285","author":"JM Eltit","year":"2010","unstructured":"Eltit JM, Feng W, Lopez JR, Padilla IT, Pessah IN, Molinski TF, et al. Ablation of skeletal muscle triadin impairs FKBP12\/RyR1 channel interactions essential for maintaining resting cytoplasmic Ca2+. J Biol Chem. 2010;285(49):38453\u201362.","journal-title":"J Biol Chem"},{"key":"243_CR184","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14659","volume":"8","author":"CS Lee","year":"2017","unstructured":"Lee CS, Hanna AD, Wang H, Dagnino-Acosta A, Joshi AD, Knoblauch M, et al. A chemical chaperone improves muscle function in mice with a RyR1 mutation. Nat Commun. 2017;8:14659.","journal-title":"Nat Commun"},{"issue":"7","key":"243_CR185","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nrneurol.2011.81","volume":"7","author":"CG Bonnemann","year":"2011","unstructured":"Bonnemann CG. The collagen VI-related myopathies: muscle meets its matrix. Nat Rev Neurol. 2011;7(7):379\u201390.","journal-title":"Nat Rev Neurol"},{"issue":"Pt 8","key":"243_CR186","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1093\/brain\/awm096","volume":"130","author":"H Zhou","year":"2007","unstructured":"Zhou H, Jungbluth H, Sewry CA, Feng L, Bertini E, Bushby K, et al. Molecular mechanisms and phenotypic variation in RYR1-related congenital myopathies. Brain. 2007;130(Pt 8):2024\u201336.","journal-title":"Brain."},{"issue":"28","key":"243_CR187","doi-asserted-by":"publisher","first-page":"25722","DOI":"10.1074\/jbc.M302165200","volume":"278","author":"T Yang","year":"2003","unstructured":"Yang T, Ta TA, Pessah IN, Allen PD. Functional defects in six ryanodine receptor isoform-1 (RyR1) mutations associated with malignant hyperthermia and their impact on skeletal excitation-contraction coupling. J Biol Chem. 2003;278(28):25722\u201330.","journal-title":"J Biol Chem"}],"container-title":["Skeletal Muscle"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13395-020-00243-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13395-020-00243-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13395-020-00243-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T12:33:36Z","timestamp":1723898016000},"score":1,"resource":{"primary":{"URL":"https:\/\/skeletalmusclejournal.biomedcentral.com\/articles\/10.1186\/s13395-020-00243-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,16]]},"references-count":187,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["243"],"URL":"https:\/\/doi.org\/10.1186\/s13395-020-00243-4","relation":{},"ISSN":["2044-5040"],"issn-type":[{"value":"2044-5040","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,16]]},"assertion":[{"value":"5 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Lawal has received support from the RYR-1 Foundation.Dr. Todd has received support from the RYR-1 Foundation.Dr. Witherspoon has received support from the RYR-1 Foundation.Dr. Dirksen is a member of scientific advisory board of the RYR-1 Foundation. Dr. Dirksen has received support from the RYR-1 Foundation, Muscular Dystrophy Association, and the NIH (AR053349).Dr. B\u00f6nnemann is a member of scientific advisory board of the RYR-1 Foundation. Dr. B\u00f6nnemann has received funding from Cure CMD.Dr. Dowling is a member of scientific advisory board of the RYR-1 Foundation and Denature, and a member of the scientific council of the Muscular Dystrophy Association. Dr. Dowling has received support from the RYR-1 Foundation and Muscular Dystrophy Association.Dr. Hamilton is a member of scientific advisory board of the RYR-1 Foundation. Dr. Hamilton has received the following support from the NIH: R01AR072602, R01AR072475, and R01AR053349. Dr. Hamilton has also received a grant from the Muscular Dystrophy Association and a gift from the McNair Foundation.Dr. Meilleur has received support from the RYR-1 Foundation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32"}}